- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04485806
Culture Media Microdroplet Geometry With Different Oil Overlay and Its Effect on Embryonic Development.
The Effect of Culture Media Microdroplet Geometry and Different Oil Overlay on Pre Implantation Embryonic Development in Dry Incubators: Prospective Randomized Study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Purpose:
to determine the effect of culture media microdroplet geometry of different culture dishes and oil overlay on the pre implantation embryo development in dry incubators
Method:
We used sibling oocytes splits between two different dishes : GPS (life global, USA) and SPL (life science, Korea) with two different oils : light mineral oil (LM)(Irvine, USA) and paraffin oil (PO)(Vitro life, Sweden). All embryos cultured in dry incubators at the same conditions.
statistical analysis done using SPSS version 23
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11728
- Ganin Fertility Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female age is ≤ 37 years old with ≥ 8 MII oocytes
- Males with normal semen parameters (WHO 2010).
- We conducted three experiments all with Siblings oocytes splits and all embryos
Exclusion Criteria:
- Oocyte or sperm donation.
- Sever male factor.
- Any contradictions to undergoing in vitro fertilization or goandotropin stimulation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: GPS / LM versus SPL/LM
to determine the effect of micro droplet geometry in 3D dishes (GPS) or 2D dishes (SPL) in combination with light mineral oil (LM).
|
Media microdroplet geometry (3D dishes) in combination with light mineral oil overlay
Media microdroplet geometry (2D dishes) in combination with light mineral oil overlay
|
|
Other: GPS/PO versus SPL/PO
to determine the effect of micro droplet geometry in 3D dishes (GPS) or 2D dishes (SPL) in combination with paraffin oil (PO).
|
Media microdroplet geometry (3D dishes) in combination with Paraffin oil overlay
Media microdroplet geometry (2D dishes) in combination with paraffin oil overlay
|
|
Other: GPS/PO versus GPS/LM
to determine the effect of oil overlay light mineral(LM) or paraffin oil (PO) in combination with paraffin oil 3D dishes (GPS).
|
Media microdroplet geometry (3D dishes) in combination with light mineral oil overlay
Media microdroplet geometry (3D dishes) in combination with Paraffin oil overlay
|
|
Other: SPL/PO versus SPL/LM
to determine the effect of oil overlay light mineral(LM) or paraffin oil (PO) in combination with paraffin oil 2D dishes (SPL).
|
Media microdroplet geometry (2D dishes) in combination with light mineral oil overlay
Media microdroplet geometry (2D dishes) in combination with paraffin oil overlay
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blastulation rate
Time Frame: 5-6 days after ICSI
|
Percentage of total blastocysts / Total cleaved embryos
|
5-6 days after ICSI
|
|
High quality blast rate
Time Frame: 5-6 days after ICSI
|
Morphological grading of trophectoderm and Inner cell mass using Gardner's criteria 1999, from grade A and B ( A is the highest quality).
Total high grade embryos/ total blast embryos.
|
5-6 days after ICSI
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fertilization rate
Time Frame: 16-19 hours of ICSI
|
Percentage of fertilized oocyte (appearance of two pronuclei) / Number of injected oocytes
|
16-19 hours of ICSI
|
|
Cleavage rate
Time Frame: 72 hours of ICSI
|
Percentage of cleaved embryos/ total number of fertilized oocytes
|
72 hours of ICSI
|
|
High quality D3 embryos
Time Frame: 72 hours of ICSI
|
High quality D3 embryos according to Gardner's criteria / total cleaved embryos
|
72 hours of ICSI
|
|
Good quality trophectoderm/inner cell mass
Time Frame: 5-6 days after ICSI
|
better grade than 3BB of blast embryos according to Gardner's criteria 1999
|
5-6 days after ICSI
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MH0002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)
Clinical Trials on GPS/LM
-
Kangbuk Samsung HospitalCompletedMyomaKorea, Republic of
-
Ryerson UniversityCompleted
-
LaNova Medicines Development Co., Ltd.Shanghai Zhongshan Hospital; First Affiliated Hospital of Zhejiang University; Sir Run Run Shaw Hospital and other collaboratorsTerminated
-
LaNova Medicines LimitedChia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingAdvanced Solid TumorChina
-
LaNova Medicines Zhejiang Co., Ltd.Completed
-
Henan Cancer HospitalRecruitingNSCLC | Brain Metastases | Leptomeningeal MetastasisChina
-
LaNova Medicines LimitedRecruiting
-
Ryerson UniversityCanadian Institutes of Health Research (CIHR); Ottawa Hospital Research Institute and other collaboratorsCompletedHIV/AIDS | Health Behavior | Sexually Transmitted InfectionCanada
-
LaNova Australia Pty LimitedCompletedAdvanced Solid TumorAustralia